ForgIng New Paths to Prevent DIabeTes (FINDIT)

NACompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

December 2, 2015

Primary Completion Date

December 1, 2018

Study Completion Date

March 30, 2020

Conditions
Prediabetes
Interventions
BEHAVIORAL

Blood Test Group Intervention

Patients randomly assigned to the Blood Test Group will complete an HbA1c blood test around the time of their next primary care appointment. Following the HbA1c test, their VA primary care provider will be notified of the test result and will be provided with a detailed interpretation of the result. Trained study staff will then provide brief counseling by phone and written information by mail about their test result. The brief counseling and written information will be based on the American Diabetes Association and National Diabetes Prevention Program guidelines and will emphasize the risk of progression to type 2 diabetes mellitus and the rationale for preventive strategies, encourage aerobic exercise and a calorie-restricted diet to promote and maintain weight loss, and set a goal of achieving and sustaining a weight loss of at least 5% of body weight.

BEHAVIORAL

Brochure Group Intervention

Participants will be asked to review a handout from the National Center for Health Promotion and Disease Prevention (NCP) on recommended screening tests and immunizations on or around the same date as their next primary care appointment.

Trial Locations (1)

48105-2303

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

All Listed Sponsors
collaborator

VA Ann Arbor Healthcare System

FED

lead

VA Office of Research and Development

FED

NCT02747108 - ForgIng New Paths to Prevent DIabeTes (FINDIT) | Biotech Hunter | Biotech Hunter